Mechanisms of allergen-specific immunotherapy (Q33945896)

30 July 2017

1 reference

title

Mechanisms of allergen-specific immunotherapy. (English)

1 reference

30 July 2017

1 reference

C A Akdis

1

1 reference

30 July 2017

K Blaser

series ordinal

2

1 reference

30 July 2017

publication date

1 June 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

55

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

522-530

1 reference

The expanding universe of T-cell subsets: Th1, Th2 and more.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Lymphokine production by human T cells in disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Lymphocyte responses and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Long-term clinical efficacy of grass-pollen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Role of interleukin 10 in specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Effects of peptide therapy on ex vivo T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific T helper cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Regulation of IgE and IgG4 responses by allergen specific T-cell clones to bee venom phospholipase A2 in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Allergen immunotherapy decreases interleukin 4 production in CD4 T cells from allergic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Induction of hapten-specific tolerance by interleukin 10 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

A CD4 T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

IL-10: a potential therapy for allergic inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

CD40 expression by human peripheral blood eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Interleukin 4 production by CD4 T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Antigen-presenting function of B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

IgE-mediated allergen presentation via Fc epsilon RI on antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Immunoglobulin E-binding structures on antigen-presenting cells present in skin and blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Antigen focusing by specific monomeric immunoglobulin E bound to CD23 on Epstein-Barr virus-transformed B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

IgE-dependent antigen focusing by human B lymphocytes is mediated by the low-affinity receptor for IgE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Effect of transmembrane and cytoplasmic domains of IgE on the IgE response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Controlled evaluations of repository therapy in ragweed hay fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Trials of alum-precipitated pollen extracts in the treatment of hay fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Immunotherapy with short ragweed fraction A:D-glutamic acid:D-lysine polymer in ragweed hay fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Studies on allergoids from naturally occurring allergens III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Physicochemical and immunologic characterization of low-molecular-weight allergoids of Dactylis glomerata pollen proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Epitope mapping of the house-dust-mite allergen Der p 2 by means of site-directed mutagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Biochemical and structural analysis of the IgE binding sites on ara h1, an abundant and highly allergenic peanut protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Contribution of disulphide bonds to antigenicity of Lep d 2, the major allergen of the dust mite Lepidoglyphus destructor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Hyposensitization to allergic reaction in rDer f 2-sensitized mice by the intranasal administration of a mutant of rDer f 2, C8/119S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen Bet v 1 and to recombinant Bet v 1 wild type in skin chamber fluids collected from birch pollen–allergic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Regulation of specific immune responses by chemical and structural modifications of allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

Isotypic and idiotypic characterization of anti-bee venom phospholipase A2 antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

7 January 2021

Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

7 January 2021

Determinants and mechanisms of human immune responses to bee venom phospholipase A2

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

7 January 2021

Treatment of cat allergy with T-cell reactive peptides

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

7 January 2021

Differential effects of IL-4 and IL-10 on IL-2-induced IFN-γ synthesis and lymphokine-activated killer activity

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

7 January 2021

Nasal Immunotherapy in Weed-Induced Allergic Rhinitis

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

7 January 2021

Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

7 January 2021

Enzymatic activity of soluble phospholipase A2 does not affect the specific IgE, IgG4 and cytokine responses in bee sting allergy

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

7 January 2021

Abrogation of reaginic antibodies with modified allergens

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

7 January 2021

Modified forms of allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

7 January 2021

Double-blind, placebo-controlled immunotherapy with a high-molecular-weight, formalinized allergoid in grass pollen allergy

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

7 January 2021

Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

7 January 2021

Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy.

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

7 January 2021

Modification of a major peanut allergen leads to loss of IgE binding

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

7 January 2021

Recombinant allergen fragments as candidate preparations for allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

7 January 2021

Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

7 January 2021

Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French population

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

7 January 2021

Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: candidates for specific immunotherapy

1 reference

https://api.crossref.org/works/10.1034/J.1398-9995.2000.00120.X

7 January 2021

10.1034/J.1398-9995.2000.00120.X

Identifiers

DOI

1 reference

30 July 2017

1 reference